New York State Common Retirement Fund
CUE icon

New York State Common Retirement Fund’s Cue Biopharma CUE Stock Holding History

New York State Common Retirement Fund’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$372 – 3219
2024
Q2 		$372 Sell
10
-387
-97% -$19.1K ﹤0.01% 3356
2024
Q1 		$22.5K Hold
397
– – ﹤0.01% 3129
2023
Q4 		$31.4K Sell
397
-2
-0.5% -$143 ﹤0.01% 3095
2023
Q3 		$27.6K Sell
399
-458
-53% -$44.7K ﹤0.01% 3148
2023
Q2 		$93.8K Buy
+857
New +$101K ﹤0.01% 2909
2022
Q3 		– Sell
-9
Closed -$1K – 3310
2022
Q2 		$1K Sell
9
-598
-99% -$69.9K ﹤0.01% 3337
2022
Q1 		$89K Buy
607
+2
+0.3% +$424 ﹤0.01% 3049
2021
Q4 		$205K Sell
605
-3
-0.5% -$1.16K ﹤0.01% 2866
2021
Q3 		$266K Sell
608
-247
-29% -$86.2K ﹤0.01% 2789
2021
Q2 		$299K Buy
855
+8
+0.9% +$3.1K ﹤0.01% 2850
2021
Q1 		$310K Hold
847
– – ﹤0.01% 2673
2020
Q4 		$318K Hold
847
– – ﹤0.01% 2564
2020
Q3 		$382K Hold
847
– – ﹤0.01% 2346
2020
Q2 		$623K Buy
847
+220
+35% +$159K ﹤0.01% 2101
2020
Q1 		$267K Hold
627
– – ﹤0.01% 2324
2019
Q4 		$298K Buy
627
+267
+74% +$83.9K ﹤0.01% 2545
2019
Q3 		$91K Hold
360
– – ﹤0.01% 3055
2019
Q2 		$97K Buy
360
+257
+250% +$63.9K ﹤0.01% 3124
2019
Q1 		$24K Hold
103
– – ﹤0.01% 3129
2018
Q4 		$15K Sell
103
-554
-84% -$101K ﹤0.01% 3164
2018
Q3 		$178K Hold
657
– – ﹤0.01% 2880
2018
Q2 		$234K Buy
+657
New +$261K ﹤0.01% 2806

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

New York State Common Retirement Fund's CUE Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 10 shares — an estimated $372 sold.

New York State Common Retirement Fund first reported a position in CUE in Q2 2018 and held it in 22 quarters. The position peaked at $623K in Q2 2020. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 10 Cue Biopharma shares in Q3 2024, an estimated $372.
  • New York State Common Retirement Fund first reported a position in Cue Biopharma in Q2 2018 and held it in 22 quarters.
  • New York State Common Retirement Fund's Cue Biopharma position peaked at $623K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.